• Continuing professional development

Allergic skin disease and drug allergy

This course covers a wide range of allergic skin diseases, including atopic eczema, contact dermatitis, urticarias, hereditary and acquired angioedemas, photodermatoses and drug allergies.

Course key facts

  • Date

    30 Apr - 21 May 2026

  • Duration

    3 weeks

  • Credits

    Non credit bearing

  • Format

    Blended

  • Fee

    £425

  • Location

    On Campus (South Ken)

Overview

This course covers a wide range of allergic skin diseases, including atopic eczema, contact dermatitis, urticarias, hereditary and acquired angioedemas, photodermatoses and drug allergies. The underlying mechanisms, diagnostic work-up and advanced management will be discussed. Challenging topics such as the role of food allergy in eczema, refractory urticaria and mastocytosis will be addressed. The course will be delivered by experts and world leading international academics.

Learning journey

The course has been devised in an attractive and innovative format combining asynchronous materials (e.g. pre-recorded sessions, reading lists and web-based resources) as well as live interactive sessions, both online and on campus. A range of formats will be used to encourage active learning, including ‘meet the expert question & answer’ sessions, focused discussions, interactive case-based sessions as well as group work. Practical ‘hands-on’ elements will be covered on the optional on campus half day.

The course forms part of a range of short courses in Allergy which are available both to students who are enrolled on the MSc in allergy programme, and as stand-alone CPD programmes for GPs, specialist trainees and consultants, nurses, dietitians and other healthcare professionals wishing to improve their ability to manage allergic patients in daily practice. The course is also suitable for basic scientists and professionals working in industry willing to further their career in the field of allergic skin diseases.

This course will be delivered in a hybrid format. This includes pre-recorded materials, live online sessions, and you can also attend in person teaching or choose to follow this online. 

A ‘course launch webinar’ will be held in April for registered participants to introduce the course and help you get organised to maximize your learning experience. 

Key dates & provisional times (UK time): 

  • Wednesday, 1 April 2026,  2.30 - 2.50pm: Launch webinar (online)
  • Thursday, 30 April 2026, 1.30 - 6.15pm:  Live online teaching
  • Monday, 11 May 2026,  1.30 - 6.00pm: Live online teaching
  • Thursday, 21 May 2026 9.00am - 12.30: Live teaching – students can choose to attend online or on campus*.

*The live hybrid teaching will be held at one of our campuses – live streaming will be made available for those that choose to follow the course online.

Course details

Module leaders

Dr Timothy Watts
Dr Timothy Watts is a Consultant Physician in Adult Allergy. His substantive consultant post is based at Homerton Healthcare NHS Foundation Trust, London, where he leads the drug allergy service. He was appointed Clinical Lead for Allergy at Homerton Healthcare in 2024.

He is an Honorary Clinical Senior Lecturer in Allergy at Imperial College London, where he is a faculty member on the MSc Allergy postgraduate programme and has been the Allergic Skin Disease & Drug Allergy Module Lead for the course since 2019.

He completed dedicated higher specialty training in Adult Allergy within Guy’s & St Thomas’ NHS Foundation Trust. He was elected to the Fellowship of the Royal College of Physicians (FRCP) in 2022. He has extensive experience in all aspects of allergic disease, with specialist clinical and research interests in delayed (Type IV) drug hypersensitivity and cutaneous allergy (patch testing), having published and presented extensively in these fields at an international level. He is also frequently invited to both chair sessions & speak on Drug Allergy at the annual BSACI National Allergy Conference.

Additionally, he developed and leads a tertiary drug patch testing service at Homerton University Hospital, which functions as a regional referral centre within London for the investigation of delayed-type drug eruptions. His clinical research in particular focuses on the utility, methodology, efficacy and safety of Drug Patch Testing, and the wider investigation of Delayed (Type IV) T-cell mediated drug hypersensitivity reactions. He is also a Member of the WAO Drug Hypersensitivity Reactions Committee and actively contributes to guidelines and consensus papers.

He frequently teaches and supervises both undergraduate students and postgraduate trainees and sits on the Specialty Training Committee for Allergy & Immunology and ARCP panels (London Deanery). He is named Clinical Supervisor and local training lead for Immunology & Allergy Specialty Registrars, and an Educational Supervisor for FY2 Doctors. Dr Watts is also an examiner for FRCPath Part 1 Examination (Allergy and Clinical Immunology Certificate Examination).

Contact us

Have a question?

We’d love to hear from you. Get in touch and a member of the team will be happy to help.